Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Entospletinib effectively prevents eye and skin GVHD in mice.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The patient recovered well and returned to college without any lasting issues.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Age-related immune changes significantly affect disease development in other systems.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Skin issues can indicate immune system problems.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Organ transplants can greatly improve life but also bring challenges, requiring empathy and better communication from providers.

Demodex folliculitis can occur in HIV patients on HAART, and treatment may involve topical creams or medication changes.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

The role of γδT-cells in causing alopecia areata remains unclear.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Co-trimoxazole may help treat autoimmune diseases.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.